<DOC>
	<DOCNO>NCT00584428</DOCNO>
	<brief_summary>To evaluate response rate response duration high dose chemotherapy autologous bone marrow transplantation intensification follow induction chemotherapy metastatic breast cancer evaluate prospectively subdivision patient metastatic breast cancer accord prognostic group .</brief_summary>
	<brief_title>High Dose Chemo With Autologous BMT Treatment Metastatic Breast Cancer</brief_title>
	<detailed_description>There 2 phase study : 1 ) Induction- consist administration chemotherapeutic drugs- end phase cancer respond , bone marrow collect frozen untol ready re-infusion ; 2 ) 2nd phase- involves high-doses chemotherapy follow infusion bone marrow cell</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Histologically confirm diagnosis breast cancer Age 1870 Breast cancer first clinical evidence metastatic disease Must objectively measurable evaluable disease complete remission Previous diagnosis another invasive carcinaom within 10 year ( except skin cancer ) CNS involvement</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>Cancer Treatment</keyword>
	<keyword>Breast Cancer Treatment</keyword>
</DOC>